Prednisolone Sodium Phosphate Oral Solution NDC 44523-182

NDC codes

FDA NDC Directory

Product NDC (as listed)44523-182Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44523-0182Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44523-182-08	44523018208	237 mL in 1 BOTTLE (44523-182-08)Marketed from Oct 28, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prednisolone Sodium Phosphate Oral Solution
Generic name (nonproprietary): prednisolone sodium phosphate
Active ingredients: Prednisolone sodium phosphate — 25 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: BioComp Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091396
Marketing start: Oct 28, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 44523-182_450e8d3f-b6f6-5251-e063-6394a90aa439SPL ID 450e8d3f-b6f6-5251-e063-6394a90aa439SPL set ID 95208441-1700-5d3f-e053-2a95a90a7da2RxCUI 249066UNII IV021NXA9JUPC 0344523182080
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444523018208 followed by a unit qualifier and the quantity

Package 44523-0182-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 3, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Prednisolone sodium phosphate oral solution (25 mg prednisolone per 5 mL) is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. 2. Dermatologic Diseases Pemphigus; bullous dermatitis herpetiformis; severe erythema multiforme (Stevens-Johnson syndrome); exfoliative erythroderma; mycosis fungoides. 3. Edematous States To induce diuresis or remission of proteinuria in nephrotic sy…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)